chr8-125024346-AAC-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_014846.4(WASHC5):c.*269_*270del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00285 in 514,106 control chromosomes in the GnomAD database, including 9 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0074 ( 8 hom., cov: 32)
Exomes 𝑓: 0.00091 ( 1 hom. )
Consequence
WASHC5
NM_014846.4 3_prime_UTR
NM_014846.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.10
Genes affected
WASHC5 (HGNC:28984): (WASH complex subunit 5) This gene encodes a 134 kDa protein named strumpellin that is predicted to have multiple transmembrane domains and a spectrin-repeat-containing domain. This ubiquitously expressed gene has its highest expression in skeletal muscle. The protein is named for Strumpell disease; a form of hereditary spastic paraplegia (HSP). Spastic paraplegias are a diverse group of disorders in which the autosomal dominant forms are characterized by progressive, lower extremity spasticity caused by axonal degeneration in the terminal portions of the longest descending and ascending corticospinal tracts. More than 30 loci (SPG1-33) have been implicated in hereditary spastic paraplegia diseases. [provided by RefSeq, Aug 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 8-125024346-AAC-A is Benign according to our data. Variant chr8-125024346-AAC-A is described in ClinVar as [Likely_benign]. Clinvar id is 361706.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00744 (1134/152342) while in subpopulation AFR AF= 0.0256 (1064/41562). AF 95% confidence interval is 0.0243. There are 8 homozygotes in gnomad4. There are 536 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WASHC5 | NM_014846.4 | c.*269_*270del | 3_prime_UTR_variant | 29/29 | ENST00000318410.12 | ||
WASHC5 | NM_001330609.2 | c.*269_*270del | 3_prime_UTR_variant | 28/28 | |||
WASHC5 | XM_047422502.1 | c.*269_*270del | 3_prime_UTR_variant | 30/30 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WASHC5 | ENST00000318410.12 | c.*269_*270del | 3_prime_UTR_variant | 29/29 | 1 | NM_014846.4 | P1 | ||
WASHC5 | ENST00000517845.5 | c.*269_*270del | 3_prime_UTR_variant | 27/27 | 2 | ||||
WASHC5 | ENST00000519042.2 | n.888_889del | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00744 AC: 1133AN: 152224Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
1133
AN:
152224
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000915 AC: 331AN: 361764Hom.: 1 AF XY: 0.000754 AC XY: 145AN XY: 192238
GnomAD4 exome
AF:
AC:
331
AN:
361764
Hom.:
AF XY:
AC XY:
145
AN XY:
192238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00744 AC: 1134AN: 152342Hom.: 8 Cov.: 32 AF XY: 0.00720 AC XY: 536AN XY: 74494
GnomAD4 genome
AF:
AC:
1134
AN:
152342
Hom.:
Cov.:
32
AF XY:
AC XY:
536
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Spastic paraplegia, autosomal dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at